These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

759 related items for PubMed ID: 19076615

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challenge.
    Haynes JR, Dokken L, Wiley JA, Cawthon AG, Bigger J, Harmsen AG, Richardson C.
    Vaccine; 2009 Jan 22; 27(4):530-41. PubMed ID: 19026705
    [Abstract] [Full Text] [Related]

  • 5. Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes.
    Pushko P, Pearce MB, Ahmad A, Tretyakova I, Smith G, Belser JA, Tumpey TM.
    Vaccine; 2011 Aug 11; 29(35):5911-8. PubMed ID: 21723354
    [Abstract] [Full Text] [Related]

  • 6. Elicitation of protective immune responses using a bivalent H5N1 VLP vaccine.
    Crevar CJ, Ross TM.
    Virol J; 2008 Oct 28; 5():131. PubMed ID: 18957098
    [Abstract] [Full Text] [Related]

  • 7. Plant-derived hemagglutinin protects ferrets against challenge infection with the A/Indonesia/05/05 strain of avian influenza.
    Shoji Y, Bi H, Musiychuk K, Rhee A, Horsey A, Roy G, Green B, Shamloul M, Farrance CE, Taggart B, Mytle N, Ugulava N, Rabindran S, Mett V, Chichester JA, Yusibov V.
    Vaccine; 2009 Feb 11; 27(7):1087-92. PubMed ID: 19100806
    [Abstract] [Full Text] [Related]

  • 8. Induction of cross-protective immunity against influenza A virus H5N1 by an intranasal vaccine with extracts of mushroom mycelia.
    Ichinohe T, Ainai A, Nakamura T, Akiyama Y, Maeyama J, Odagiri T, Tashiro M, Takahashi H, Sawa H, Tamura S, Chiba J, Kurata T, Sata T, Hasegawa H.
    J Med Virol; 2010 Jan 11; 82(1):128-37. PubMed ID: 19950232
    [Abstract] [Full Text] [Related]

  • 9. Immunogenicity of hemagglutinin from A/Bar-headed Goose/Qinghai/1A/05 and A/Anhui/1/05 strains of H5N1 influenza viruses produced in Nicotiana benthamiana plants.
    Shoji Y, Farrance CE, Bi H, Shamloul M, Green B, Manceva S, Rhee A, Ugulava N, Roy G, Musiychuk K, Chichester JA, Mett V, Yusibov V.
    Vaccine; 2009 May 26; 27(25-26):3467-70. PubMed ID: 19200814
    [Abstract] [Full Text] [Related]

  • 10. The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza.
    D'Aoust MA, Couture MM, Charland N, Trépanier S, Landry N, Ors F, Vézina LP.
    Plant Biotechnol J; 2010 Jun 26; 8(5):607-19. PubMed ID: 20199612
    [Abstract] [Full Text] [Related]

  • 11. Production and characterization of mammalian virus-like particles from modified vaccinia virus Ankara vectors expressing influenza H5N1 hemagglutinin and neuraminidase.
    Schmeisser F, Adamo JE, Blumberg B, Friedman R, Muller J, Soto J, Weir JP.
    Vaccine; 2012 May 14; 30(23):3413-22. PubMed ID: 22465746
    [Abstract] [Full Text] [Related]

  • 12. Immunogenicity of H1N1 influenza virus-like particles produced in Nicotiana benthamiana.
    Shoji Y, Prokhnevsky A, Leffet B, Vetter N, Tottey S, Satinover S, Musiychuk K, Shamloul M, Norikane J, Jones RM, Chichester JA, Green BJ, Streatfield SJ, Yusibov V.
    Hum Vaccin Immunother; 2015 May 14; 11(1):118-23. PubMed ID: 25483524
    [Abstract] [Full Text] [Related]

  • 13. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M, Velumani S, He F, Karuppannan AK, Geng GY, Yin LK, Kwang J.
    Virology; 2008 Oct 25; 380(2):412-20. PubMed ID: 18786689
    [Abstract] [Full Text] [Related]

  • 14. Recombinant H1N1 virus-like particle vaccine elicits protective immunity in ferrets against the 2009 pandemic H1N1 influenza virus.
    Pushko P, Kort T, Nathan M, Pearce MB, Smith G, Tumpey TM.
    Vaccine; 2010 Jul 05; 28(30):4771-6. PubMed ID: 20470801
    [Abstract] [Full Text] [Related]

  • 15. Preclinical evaluation of a modified vaccinia virus Ankara (MVA)-based vaccine against influenza A/H5N1 viruses.
    Kreijtz JH, Suezer Y, de Mutsert G, van den Brand JM, van Amerongen G, Schnierle BS, Kuiken T, Fouchier RA, Löwer J, Osterhaus AD, Sutter G, Rimmelzwaan GF.
    Vaccine; 2009 Oct 23; 27(45):6296-9. PubMed ID: 19840663
    [Abstract] [Full Text] [Related]

  • 16. Generation and characterization of a trackable plant-made influenza H5 virus-like particle (VLP) containing enhanced green fluorescent protein (eGFP).
    Young KR, Arthus-Cartier G, Yam KK, Lavoie PO, Landry N, D'Aoust MA, Vézina LP, Couture MM, Ward BJ.
    FASEB J; 2015 Sep 23; 29(9):3817-27. PubMed ID: 26038124
    [Abstract] [Full Text] [Related]

  • 17. Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge.
    Govorkova EA, Webby RJ, Humberd J, Seiler JP, Webster RG.
    J Infect Dis; 2006 Jul 15; 194(2):159-67. PubMed ID: 16779721
    [Abstract] [Full Text] [Related]

  • 18. A pseudotype baculovirus-mediated vaccine confers protective immunity against lethal challenge with H5N1 avian influenza virus in mice and chickens.
    Wu Q, Fang L, Wu X, Li B, Luo R, Yu Z, Jin M, Chen H, Xiao S.
    Mol Immunol; 2009 Jul 15; 46(11-12):2210-7. PubMed ID: 19446339
    [Abstract] [Full Text] [Related]

  • 19. DNA vaccination with a single-plasmid construct coding for viruslike particles protects mice against infection with a highly pathogenic avian influenza A virus.
    Szécsi J, Gabriel G, Edfeldt G, Michelet M, Klenk HD, Cosset FL.
    J Infect Dis; 2009 Jul 15; 200(2):181-90. PubMed ID: 19505256
    [Abstract] [Full Text] [Related]

  • 20. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
    Pavlova SP, Veits J, Keil GM, Mettenleiter TC, Fuchs W.
    Vaccine; 2009 Jan 29; 27(5):773-85. PubMed ID: 19041677
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.